Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study
Author:
Affiliation:
1. Department of Anesthesiology; China Medical University Hospital; Taichung Taiwan
2. Department of Health Services Administration; China Medical University; Taichung Taiwan
3. College of Medicine; China Medical University; Taichung Taiwan
Funder
Taiwan Department of Health Clinical Trial and Research Center of Excellence
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12228/fullpdf
Reference38 articles.
1. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread;Carl-McGrath;Cancer Biol Ther,2007
2. Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk;Sipahi;Am J Cardiol,2011
3. Treatment of kidney transplant recipients with ACEi/ARB and risk of respiratory tract cancer: a collaborative transplant study report;Opelz;Am J Transplant,2011
4. Angiotensin II receptor blockers and risk of cancer: cause for concern?;Rahbari-Oskoui;Am J Kidney Dis,2011
5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review;McMenamin;Cancer Causes Cont,2012
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review);World Academy of Sciences Journal;2024-07-08
2. Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy;Journal of Orthopaedic Surgery and Research;2024-02-19
3. The Renin-Angiotensin System and Cancer;The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases;2023
4. Dipeptidyl peptidase 4 (DPP-4) inhibitors and the risk of lung cancer: current evidence and future directions;Expert Review of Clinical Pharmacology;2022-12-28
5. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment;Biomedicines;2022-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3